SMARCB1 and urinary bladder neoplasm: Autopsy with subsequent immunoprofile and molecular testing were crucial in establishing the absence of INI1 nuclear expression and possible homozygous deletion of <i>SMARCB1</i> in the urinary bladder tumor tissue.